BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 21454650)

  • 1. Interferon regulatory factor 4 (IRF-4) targets IRF-5 to regulate Epstein-Barr virus transformation.
    Xu D; Meyer F; Ehlers E; Blasnitz L; Zhang L
    J Biol Chem; 2011 May; 286(20):18261-7. PubMed ID: 21454650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manipulation of the toll-like receptor 7 signaling pathway by Epstein-Barr virus.
    Martin HJ; Lee JM; Walls D; Hayward SD
    J Virol; 2007 Sep; 81(18):9748-58. PubMed ID: 17609264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon regulatory factor 4 is involved in Epstein-Barr virus-mediated transformation of human B lymphocytes.
    Xu D; Zhao L; Del Valle L; Miklossy J; Zhang L
    J Virol; 2008 Jul; 82(13):6251-8. PubMed ID: 18417578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic IRFs provide a survival advantage for Epstein-Barr virus- or human T-cell leukemia virus type 1-transformed cells through induction of BIC expression.
    Wang L; Toomey NL; Diaz LA; Walker G; Ramos JC; Barber GN; Ning S
    J Virol; 2011 Aug; 85(16):8328-37. PubMed ID: 21680528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The EBV Latent Antigen 3C Inhibits Apoptosis through Targeted Regulation of Interferon Regulatory Factors 4 and 8.
    Banerjee S; Lu J; Cai Q; Saha A; Jha HC; Dzeng RK; Robertson ES
    PLoS Pathog; 2013; 9(5):e1003314. PubMed ID: 23658517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual functions of interferon regulatory factors 7C in Epstein-Barr virus-mediated transformation of human B lymphocytes.
    Zhao Y; Xu D; Jiang Y; Zhang L
    PLoS One; 2010 Mar; 5(3):e9459. PubMed ID: 20209099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr Virus (EBV) Latent Protein EBNA3A Directly Targets and Silences the
    Bazot Q; Paschos K; Allday MJ
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29367247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor Suppressor p53 Stimulates the Expression of Epstein-Barr Virus Latent Membrane Protein 1.
    Wang Q; Lingel A; Geiser V; Kwapnoski Z; Zhang L
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28794023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression profile of nuclear receptors upon Epstein -- Barr virus induced B cell transformation.
    Yenamandra SP; Lundin A; Arulampalam V; Yurchenko M; Pettersson S; Klein G; Kashuba E
    Exp Oncol; 2009 Jun; 31(2):92-6. PubMed ID: 19550398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon regulatory factor 7: a key cellular mediator of LMP-1 in EBV latency and transformation.
    Zhang L; Pagano JS
    Semin Cancer Biol; 2001 Dec; 11(6):445-53. PubMed ID: 11669606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon regulatory factor 7 is involved in the growth of Epstein-Barr virus-transformed human B lymphocytes.
    Xu D; Zhang Y; Zhao L; Cao M; Lingel A; Zhang L
    Virus Res; 2015 Jan; 195():112-8. PubMed ID: 25300801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear receptors and their role in Epstein -- Barr virus induced B cell transformation.
    Yenamandra SP; Klein G; Kashuba E
    Exp Oncol; 2009 Jun; 31(2):67-73. PubMed ID: 19550394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon regulatory factor 8 regulates caspase-1 expression to facilitate Epstein-Barr virus reactivation in response to B cell receptor stimulation and chemical induction.
    Lv DW; Zhang K; Li R
    PLoS Pathog; 2018 Jan; 14(1):e1006868. PubMed ID: 29357389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypermethylation of the interferon regulatory factor 5 promoter in Epstein-Barr virus-associated gastric carcinoma.
    Dong SM; Lee HG; Cho SG; Kwon SH; Yoon H; Kwon HJ; Lee JH; Kim H; Park PG; Kim H; Hayward SD; Park JH; Lee JM
    J Microbiol; 2015 Jan; 53(1):70-6. PubMed ID: 25557482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus nuclear antigen 3C stabilizes Gemin3 to block p53-mediated apoptosis.
    Cai Q; Guo Y; Xiao B; Banerjee S; Saha A; Lu J; Glisovic T; Robertson ES
    PLoS Pathog; 2011 Dec; 7(12):e1002418. PubMed ID: 22174681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD21 (Complement Receptor 2) Is the Receptor for Epstein-Barr Virus Entry into T Cells.
    Smith NA; Coleman CB; Gewurz BE; Rochford R
    J Virol; 2020 May; 94(11):. PubMed ID: 32238579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IRF4 promotes Epstein-Barr virus activation in Burkitt's lymphoma cells.
    Gao Y; Wang L; Lei Z; Li J; Forrest JC; Liang X
    J Gen Virol; 2019 May; 100(5):851-862. PubMed ID: 30907723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus and the germinal center B cells.
    Khan G
    Exp Hematol; 2006 Jun; 34(6):695-6. PubMed ID: 16728272
    [No Abstract]   [Full Text] [Related]  

  • 19. C-terminal region of EBNA-2 determines the superior transforming ability of type 1 Epstein-Barr virus by enhanced gene regulation of LMP-1 and CXCR7.
    Cancian L; Bosshard R; Lucchesi W; Karstegl CE; Farrell PJ
    PLoS Pathog; 2011 Jul; 7(7):e1002164. PubMed ID: 21857817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon regulatory factor 7 is induced by Epstein-Barr virus latent membrane protein 1.
    Zhang L; Pagano JS
    J Virol; 2000 Feb; 74(3):1061-8. PubMed ID: 10627515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.